Precision Optical Guidance for Oral Biopsy

Recruiting now · Not applicable

Conditions studied: Oral Lesions

In brief

To learn if a new type of imaging device called the Active Biopsy Guidance System can help doctors to decide when and where to perform invasive biopsies of mouth lesions.

Key facts

Study ID

NCT05554133

Run by

M.D. Anderson Cancer Center

People needed

90

Starts

2023-06-15

Expected to finish

2027-03-31

Last updated by the study team

2026-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult subjects with clinically evident oral lesions such as leukoplakia or erythroplakia, oral potentially malignant disorders (OPMD) such as lichen planus and graft vs. host disease, pathologic diagnosis of dysplasia, squamous cell carcinoma, or a history of resected oral cancer, are eligible to participate. Patients with previous treatment including surgery, radiation, chemotherapy or other therapies are also eligible.
• Ability to understand and willingness to sign a written Informed Consent Document (ICD).

You may not qualify if…

• Known allergy to proflavine or acriflavine.
• Age less than 18 years.
• Pregnant or nursing females.
• Adults unable to consent
• Prisoners and other vulnerable populations

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.